Where it comes from
- Made in
- The arcuate nucleus of the hypothalamus and the median eminence; a separate pool sits in the glial cells of the posterior pituitary
- Sent out by
- Leptin and feeding raise it; fasting lowers it
- Acts on
- Feeding circuits
- GnRH neurons
- Thermoregulation
What it does
In medicine
- No medicine copies it or blocks it, and it is not measured in people
- It has no human data of any kind: everything known about it comes from rodents and from the pig hypothalamus it was isolated from 1
Beyond the body’s own use
- Intranasal GALP held weight down in obese mice in one laboratory’s work, alongside less movement; no human trial has been run 2
- Its fever is not a metabolic effect. The rise in temperature runs through interleukin-1 and prostaglandins, and blocking those blocks the fever and the loss of appetite with it, which argues that part of the weight loss is simply feeling unwell 3
- Nothing containing GALP is approved or obtainable outside the laboratory. The open question is whether its appetite effect can be separated from that illness response at all 3
Sources
- Ohtaki et al., Isolation and cDNA cloning of galanin-like peptide from porcine hypothalamus, Journal of Biological Chemistry 1999
- Kageyama et al., Anti-obesity effect of intranasal galanin-like peptide in obese mice, Scientific Reports 2016
- Man & Lawrence, Interleukin-1 mediates the anorexic and febrile actions of galanin-like peptide, Endocrinology 2008
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.